SamiIbrahimiMD

Oncology • Oklahoma City, OK

Hematologic Oncology

Physician

Join to view full profile

Dr. Ibrahimi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ibrahimi's full profile

Already have an account?

Office
800 NE 10th St
Stephenson Cancer Center
Oklahoma City, OK 73104
Phone+1 405-271-4022

Education & Training

University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
UMass Chan - BaystateResidency, Internal Medicine, 2012 - 2015
University of Jordan Faculty of MedicineClass of 2010

Certifications & Licensure

OK State Medical License 2015 - 2025
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

110 citations
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.
Jeremy S Abramson, Scott R Solomon, Jon Arnason, Patrick B Johnston, Bertram Glass
Blood. 2023-04-06
534 citations
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade
Ziming Wang, Ethan G. Aguilar, Jesus I. Luna, Cordelia Dunai, Lam T. Khuat
Nature Medicine. 2019-01-01
2 citations
Spontaneous Regression of Metastatic Pancreatic Cancer: A Role for Recurrent Inflammation.
Sami Ibrahimi, Sarbajit Mukherjee, Laith Alhyari, Erin Rubin, Raid Aljumaily
Pancreas. 2019-01-01

Journal Articles

Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint Blockade
R Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature

Lectures

Role of Somatic Mutations and Clonal Thrombopoiesis in Immune Thrombocytopenia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Thrombocytopenia Is a Biomarker for Response in Patients Treated with Anti PD-1/Pdl-1 Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Study from OU Medicine Shows Why Obese Patients Respond Better to ImmunotherapyDecember 5th, 2018